Global Tumor Mice Model Market Growth 2023-2029
Syngeneic mice retain an intact immune system; therefore, they are specifically used in immune-oncology studies. Cancer immunotherapies are designed to work in conjunction with a patient’s immune system to increase natural anti-tumor response.Oncology Mice Models Market Segmented By Humanized Immune System Mice Models, Syngeneic Tumor Mice Models, Immunodeficient Mice Models, NOG Mice Models, Spontaneous Tumor Mice Models Product
LPI (LP Information)' newest research report, the “Tumor Mice Model Industry Forecast” looks at past sales and reviews total world Tumor Mice Model sales in 2022, providing a comprehensive analysis by region and market sector of projected Tumor Mice Model sales for 2023 through 2029. With Tumor Mice Model sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tumor Mice Model industry.
This Insight Report provides a comprehensive analysis of the global Tumor Mice Model landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tumor Mice Model portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Tumor Mice Model market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tumor Mice Model and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tumor Mice Model.
The global Tumor Mice Model market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Tumor Mice Model is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Tumor Mice Model is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Tumor Mice Model is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Tumor Mice Model players cover The Jackson Laboratory, Taconic Biosciences, Charles River Laboratories, Shanghai Model Organisms Center Inc., Envigo, Biocytogen, Genoway, Crown Bioscience Inc. and Cyagen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Tumor Mice Model market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Humanized Immune System Mice Models
Syngeneic Tumor Mice Models
Immunodeficient Mice Models
NOG Mice Models
Spontaneous Tumor Mice Models
Others
Segmentation by application
Contract Research Organizations
Pharma and Biopharma Companies
Academic and Research Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
The Jackson Laboratory
Taconic Biosciences
Charles River Laboratories
Shanghai Model Organisms Center Inc.
Envigo
Biocytogen
Genoway
Crown Bioscience Inc.
Cyagen
Applied Stem Cells
Ingenious Targeting Laboratory
PolyGene-Transgenic mice model company
Creative Biolabs
TransCure Bioservices
Champions Oncology Inc
Certis Oncology
Signature
Pharmaron
Laboratory Corporation of America Holdings
Gempharmatech
Janvier Labs
Harbour BioMed
Key Questions Addressed in this Report
What is the 10-year outlook for the global Tumor Mice Model market?
What factors are driving Tumor Mice Model market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tumor Mice Model market opportunities vary by end market size?
How does Tumor Mice Model break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook